Skip to content

Navigating Through the Lipid Injectable Emulsions (ILEs) in the US

4:15 PM - 5:45 PM


  1. Discuss indications for various types of intravenous lipids in the NICU
  2. Discuss the safe use of the various lipid products available in the US within the pediatric population
  3. Describe the various issues (including compatibility) encountered with attempting to give the various lipid products to the pediatric population
  4. Monitor long-term use of ILE in the home patient population including treatment and prevention of chronic disease
  5. Utilize the Omega-3 Index and the Fatty Acid Panel to monitor dosing of ILE’s


Can Someone Please Tell Me How to Give These New Lipids Safely?

Beth Deen, PharmD, BCNSP, BCPPS, Senior Clinical Pharmacy Specialist, Cook Children’s Medical Center, Fort Worth, TX

Intravenous Lipids in the NICU: Indications and Clinical Outcomes
Kara Calkins, MD, MS, Assistant Professor, Department of Pediatrics, University of California Los Angeles, Los Angeles, CA

ILE in the Long-Term Patient for Chronic Disease Prevention as well as Objective Testing to Help Guide Our Dosing and Management
Merin Kinikini, DNP, FNP, RD, CNSC, IFMCP, Nurse Practitioner, Intermountain Medical Center Nutrition Support, Murray, Utah; Adjunct Faculty, Department of Nursing, University of Utah, Salt Lake City, UT

Beth Deen, PharmD, BCNSP, BCPPS

CE Credit: 1.5 hours
Level: Intermediate
UAN: JA0002345-0000-20-044-L04-P

Presented by the ASPEN Parenteral Nutrition Safety Committee and Pharmacy Section

BPS logo blue_2020This session has been approved for BCNSP recertification credit of 1.5 hours.